Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.2540
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of $25.15 million as of September 18, 2025. Its market cap has increased by 74.58% in one year.
Market Cap
25.15M
Enterprise Value
24.37M
Revenue
113.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 35.57M to 25.15M, a decrease of -29.28%. That is a compound annual growth rate of -3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 25.15M | 144.73% |
| Dec 30, 2024 | 10.28M | -24.05% |
| Dec 29, 2023 | 13.53M | 27.76% |
| Dec 30, 2022 | 10.59M | -28.16% |
| Dec 30, 2021 | 14.74M | 116.26% |
| Dec 30, 2020 | 6.82M | -49.96% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 792.01M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |